VIVUS Inc (NASDAQ:VVUS)
| 13.22 Real-Time Quote |  +0.06 / +0.46%Today’s Change | 9.86 Today|||52-Week Range 31.21 | -1.49% Year-to-Date |
Latest VVUS News | Press Releases
| ARNA Sheds Light on Belviq Launch - Analyst Blog May 09 / Zacks.com | VIVUS Reports Wider Loss - Analyst Blog May 09 / Zacks.com |
Today’s Trading
| Previous close | 13.16 |
| Today’s open | 13.21 |
| Day’s range | 13.17 - 13.52 |
| Volume | 522,708 |
| Average volume (3 months) | 2,479,252 |
| Market cap | $1.3B |
| Dividend yield | -- |
Data as of 11:12am ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -158.18% |
| Earnings growth (this year) | -26.86% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 655.59 |
| Price/Book | 5.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACORAcorda Therapeutics ... | +0.25 | +0.77% |
| NPSPNPS Pharmaceuticals ... | +1.81 | +12.46% |
| IPXLImpax Laboratories I... | +0.13 | +0.70% |
| INFIInfinity Pharmaceuti... | -1.96 | -7.80% |
Data as of 11:15am ET, 05/22/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$139.9M |
| Net profit margin | -6,944.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President & Director Peter Y. Tam, MBA |
Chief Executive Officer & Director Leland F. Wilson |
Corporate headquarters Mountain View, California |
Forecasts
